- Home
- IMXI vs DCTH Comparison
IMXI vs DCTH Comparison
Compare IMXI & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMXI
- DCTH
- Stock Information
- Founded
- IMXI 1994
- DCTH 1988
- Country
- IMXI United States
- DCTH United States
- Employees
- IMXI N/A
- DCTH N/A
- Industry
- IMXI Retail: Computer Software & Peripheral Equipment
- DCTH Medical/Dental Instruments
- Sector
- IMXI Technology
- DCTH Health Care
- Exchange
- IMXI Nasdaq
- DCTH Nasdaq
- Market Cap
- IMXI 559.5M
- DCTH 518.0M
- IPO Year
- IMXI N/A
- DCTH N/A
- Fundamental
- Price
- IMXI $12.43
- DCTH $12.11
- Analyst Decision
- IMXI Buy
- DCTH Strong Buy
- Analyst Count
- IMXI 7
- DCTH 4
- Target Price
- IMXI $24.40
- DCTH $22.75
- AVG Volume (30 Days)
- IMXI 344.0K
- DCTH 452.3K
- Earning Date
- IMXI 05-07-2025
- DCTH 05-13-2025
- Dividend Yield
- IMXI N/A
- DCTH N/A
- EPS Growth
- IMXI 9.82
- DCTH N/A
- EPS
- IMXI 1.79
- DCTH N/A
- Revenue
- IMXI $658,649,000.00
- DCTH $37,205,000.00
- Revenue This Year
- IMXI $2.91
- DCTH $128.78
- Revenue Next Year
- IMXI $4.40
- DCTH $54.07
- P/E Ratio
- IMXI $6.94
- DCTH N/A
- Revenue Growth
- IMXI N/A
- DCTH 1701.69
- 52 Week Low
- IMXI $11.27
- DCTH $5.12
- 52 Week High
- IMXI $22.38
- DCTH $16.97
- Technical
- Relative Strength Index (RSI)
- IMXI 45.24
- DCTH 49.94
- Support Level
- IMXI $11.88
- DCTH $11.74
- Resistance Level
- IMXI $12.71
- DCTH $13.09
- Average True Range (ATR)
- IMXI 0.56
- DCTH 0.83
- MACD
- IMXI 0.19
- DCTH 0.17
- Stochastic Oscillator
- IMXI 77.85
- DCTH 70.39
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.